Cloning and functional characterization of a novel c-mpl variant expressed in human CD34 cells and platelets

Cytokine

Volumn 12, Issue 7, 2000, Pages 835-844

  Li, Junzhi ^a   Sabath, Diana F ^b   Kuter, David J ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

c mpl; CD34 cells; Megakaryocyte; Platelet; Thrombopoietin

Indexed keywords

CD34 ANTIGEN; CYTOKINE; CYTOKINE RECEPTOR; IODINE 125; ISOPROTEIN; RECOMBINANT THROMBOPOIETIN; RNA; THROMBOPOIETIN;

ALTERNATIVE RNA SPLICING; ARTICLE; CELL DIFFERENTIATION; CELL MEMBRANE; CONTROLLED STUDY; EXON; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MEGAKARYOCYTE; MOLECULAR CLONING; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; THROMBOCYTE;

EID: 0033926164     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1999.0654     Document Type: Article

References (41)

1. Kaushansky K (1997) Thrombopoietin: understanding and manipulating platelet production. Annu Rev Med 48:1-11.
2. Kuter DJ (1997) In vivo effects of Mpl ligand administration and emerging clinical applications for the Mpl ligands. Curr Opin Hematol 4:163-170.
3. Sattler M, Durstin MA, Frank DA, Okuda K, Kaushansky K, Salgia R, Griffin JD (1995) The thrombopoietin receptor c-MPL activates JAK2 and TYK2 tyrosine kinases. Exp Hematol 23: 1040-1048.
4. Kuter DJ, Rosenberg RD (1995) The reciprocal relationship of thrombopoietin (c-Mpl ligand) to changes in the platelet mass during busulfan-induced thrombocytopenia in the rabbit. Blood 85:2720-2730.
5. Kaushansky K (1998) Thrombopoietin and the hematopoietic stem cell. Blood 92:1-3.
6. Vigon I, Mornon JP, Cocault L, Mitjavila MT, Tambourin P, Gisselbrecht S, Souyri M (1992) Molecular cloning and characterization of MPL, the human homolog of the v-mpl oncogene: identification of a member of the hematopoietic growth factor receptor superfamily. Proc Natl Acad Sci USA 89:5640-5644.
7. Drachman JG, Kaushansky K (1995) Structure and function of the cytokine receptor superfamily. Curr Opin Hematol 2:22-28.
8. Kiladjian JJ, Elkassar N, Hetet G, Briere J, Grandchamp B, Gardin C (1997) Study of the thrombopoitin receptor in essential thrombocythemia. Leukemia 11:1821-1826.
9. Li J, Xia Y, Kuter DJ (1996) Analysis of the thrombopoietin receptor (MPL) on platelets from normal and essential thrombocythemic (ET) patients. Blood 88:S2168.
10. Fielder PJ, Hass P, Nagel M, Stefanich E, Widmer R, Bennett GL, Keller GA, de Sauvage FJ, Eaton D (1997) Human platelets as a model for the binding and degradation of thrombopoietin. Blood 89:2782-2788.
11. Broudy VC, Lin NL, Sabath DF, Papayannopoulou T, Kaushansky K (1997) Human platelets display high-affinity receptors for thrombopoietin. Blood 89:1896-1904.
12. Alexander WS, Metcalf D, Dunn AR (1995) Point mutations within a dimer interface homology domain of c-Mpl induce constitutive receptor activity and tumorigenicity. EMBO J 14:5569-5578.
13. Drachman JG, Griffin JD, Kaushansky K (1995) The c-Mpl ligand (thrombopoietin) stimulates tyrosine phosphorylation of Jak2, Shc, and c-Mpl. J Biol Chem 270:4979-4982.
14. Ezumi Y, Takayama H, Okuma M (1995) Thrombopoietin, c-Mpl ligand, induces tyrosine phosphorylation of Tyk2, JAK2, and STAT3, and enhances agonists-induced aggregation in platelets in vitro. FEBS Lett 374:48-52.
15. Hill RJ, Zozulya S, Lu YL, Hollenbach PW, Joyce-Shaikh B, Bogenberger J, Gishizky ML (1996) Differentiation induced by the c-Mpl cytokine receptor is blocked by mutant Shc adaptor protein. Cell Growth Differ 7:1125-1134.
16. Miyakawa Y, Oda A, Druker BJ, Ozaki K, Handa M, Ohashi H, Ikeda Y (1997) Thrombopoietin and thrombin induce tyrosine phosphorylation of Vav in human blood platelets. Blood 89:2789-2798.
17. Miyakawa Y, Oda A, Druker BJ, Kato T, Miyazaki H, Handa M, Ikeda Y (1995) Recombinant thrombopoietin induces rapid protein tyrosine phosphorylation of Janus kinase 2 and Shc in human blood platelets. Blood 86:23-27.
18. Mu SX, Xia M, Elliott G, Bogenberger J, Swift S, Bennett L, Lappinga DL, Hecht R, Lee R, Saris CJ (1995) Megakaryocyte growth and development factor and interleukin-3 induce patterns of protein-tyrosine phosphorylation that correlate with dominant differentiation over proliferation of mpl-transfected 32D cells. Blood 86:4532-4543.
19. Oda A, Ozaki K, Druker BJ, Miyakawa Y, Miyazaki H, Handa M, Morita H, Ohashi H, Ikeda Y (1996) p120c-cbl is present in human blood platelets and is differentially involved in signaling by thrombopoietin and thrombin. Blood 88:1330-1338.
20. Ooi J, Tojo A, Asano S, Sato Y, Oka Y (1998) Thrombopoietin induces tyrosine phosphorylation of a common beta subunit of GM-CSF receptor and its association with Stat5 in TF-1/TPO cells. Biochem Biophys Res Commun 246:132-136.
21. Sattler M, Salgia R, Durstin MA, Prasad KV, Griffin JD (1997) Thrombopoietin induces activation of the phosphatidylinositol-3′ kinase pathway and formation of a complex containing p85PI3K and the protooncoprotein p120CBL. J Cell Physiol 171:28-33.
22. Sasaki K, Odai H, Hanazono Y, Ueno H, Ogawa S, Langdon WY, Tanaka T, Miyagawa K, Mitani K, Yazaki Y et al. (1995) TPO/c-mpl ligand induces tyrosine phosphorylation of multiple cellular proteins including proto-oncogene products, Vav and c-Cbl, and Ras signaling molecules. Biochem Biophys Res Commun 216:338-347.
23. Drachman JG, Kaushansky K (1997) Dissecting the thrombopoietin receptor: functional elements of the Mpl cytoplasmic domain. Proc Natl Acad Sci USA 94:2350-2355.
24. Li J, Xia Y, Kuter DJ (1999) Interaction of thrombopoietin with the platelet c-mpl receptor in plasma: binding, internalization, stability, and pharmacokinetics. Br J Haematol 106:345-356.
25. Mignotte V, Vigon I, Boucher de Crevecoeur E, Romeo PH, Lemarchandel V, Chretien S (1994) Structure and transcription of the human c-mpl gene (MPL). Genomics 20:5-12.
26. Souyri M, Vigon I, Penciolelli JF, Heard JM, Tambourin P, Wendling F (1990) A putative truncated cytokine receptor gene transduced by the myeloproliferative leukemia virus immortalizes hematopoietic progenitors. Cell 63:1137-1147.
27. Wendling F, Tambourin P (1991) The oncogene V-MPL, a putative truncated cytokine receptor which immortalizes hematopoietic progenitors. Nouv Rev Fr Hematol 33:145-146.
28. Montrucchio G, Brizzi MF, Calosso G, Marengo S, Pegoraro L, Camussi G (1996) Effects of recombinant human megakaryocyte growth and development factor on platelet activation. Blood 87:2762-2768.
29. Fontenay-Roupie M, Dupont JM, Picard F, Fichelson S, Botella A, Melle J, Guesnu M, Casadevall N, Dreyfus F, Bouscary D (1998) Analysis of megakaryocyte growth and development factor (thrombopoietin) effects on blast cell and megakaryocyte growth in myelodysplasia. Leuk Res 22:527-535.
30. Yan XQ, Lacey D, Hill D, Chen Y, Fletcher F, Hawley RG, McNiece IK (1996) A model of myelofibrosis and osteosclerosis in mice induced by overexpressing thrombopoietin (mpl ligand): reversal of disease by bone marrow transplantation. Blood 88: 402-409.
31. Abina MA, Tulliez M, Lacout C, Debili N, Villeval JL, Pflumio F, Wendling F, Vainchenker W, Haddada H (1998) Major effects of TPO delivered by a single injection of a recombinant adenovirus on prevention of septicemia and anemia associated with myelosuppression in mice: risk of sustained expression inducing myelofibrosis due to immunosuppression. Gene Ther 5:497-506.
32. Villeval JL, Cohen-Solal K, Tulliez M, Giraudier S, Guichard J, Burstein SA, Cramer EM, Vainchenker W, Wendling F (1997) High thrombopoietin production by hematopoietic cells induces a fatal myeloproliferative syndrome in mice. Blood 90: 4369-4383.
33. Cocault L, Bouscary D, Le Bousse Kerdiles C, Clay D, Picard F, Gisselbrecht S, Souyri M (1996) Ectopic expression of murine TPO receptor (c-mpl) in mice is pathogenic and induces erythroblastic proliferation. Blood 88:1656-1665.
34. Debili N, Wendling F, Katz A, Guichard J, Breton-Gorius J, Hunt P, Vainchenker W (1995) The Mpl-ligand or thrombopoietin or megakaryocyte growth and differentiative factor has both direct proliferative and differentiative activities on human megakaryocyte progenitors. Blood 86:2516-2525.
35. Solar GP, Kerr WG, Zeigler FC, Hess D, Donahue C, de Sauvage FJ, Eaton DL (1998) Role of c-mpl in early hematopoiesis. Blood 92:4-10.
36. Sabath DF, Kaushansky K, Broudy VC (1999) Deletion of the extracellular membrane-distal cytokine receptor homology module of Mpl results in constitutive cell growth and loss of thrombopoietin binding. Blood 94:365-367.
37. Knossos RNA. Blood 64:311-313.
38. E-globin gene. Nature 300:768-769.
39. 26Glu- >Lys). J Clin Invest 68:118-126.
40. Rollinger-Holzinger I, Griesser U, Pollak V, Zwierzina H (1998) Expression and regulation of the thrombopoietin receptor variants MPLP and MPLK in PBMC. Cytokine 10:795-802.
41. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival. J Immunol Methods 65:55-63.